Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 412

1.
2.
3.
4.

Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.

König HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J; ESEMeD/MHEDEA 2000 Investigators..

Med Care. 2009 Feb;47(2):255-61. doi: 10.1097/MLR.0b013e318184759e.

PMID:
19169128
5.
6.

Comparison of the EQ-5D and SF-12 in an adult US sample.

Johnson JA, Coons SJ.

Qual Life Res. 1998 Feb;7(2):155-66.

PMID:
9523497
7.

Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey.

Cunillera O, Tresserras R, Rajmil L, Vilagut G, Brugulat P, Herdman M, Mompart A, Medina A, Pardo Y, Alonso J, Brazier J, Ferrer M.

Qual Life Res. 2010 Aug;19(6):853-64. doi: 10.1007/s11136-010-9639-z.

PMID:
20354795
8.

Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness.

Haywood KL, Garratt AM, Dziedzic K, Dawes PT.

Rheumatology (Oxford). 2002 Dec;41(12):1380-7.

PMID:
12468817
9.

Reliability and validity of the SF-12v2 in the medical expenditure panel survey.

Cheak-Zamora NC, Wyrwich KW, McBride TD.

Qual Life Res. 2009 Aug;18(6):727-35. doi: 10.1007/s11136-009-9483-1.

PMID:
19424821
10.

Validity of SF-12 summary scores in a Greek general population.

Kontodimopoulos N, Pappa E, Niakas D, Tountas Y.

Health Qual Life Outcomes. 2007 Sep 28;5:55.

11.

[Measuring preferences for depressive health states].

König HH, Bernert S, Angermeyer MC.

Psychiatr Prax. 2005 Apr;32(3):122-31. German.

PMID:
15818528
12.

Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population.

Franks P, Lubetkin EI, Gold MR, Tancredi DJ.

Med Care. 2003 Nov;41(11):1277-83.

PMID:
14583690
13.

Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.

Lawrence WF, Fleishman JA.

Med Decis Making. 2004 Mar-Apr;24(2):160-9.

PMID:
15090102
14.

Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.

Badia X, Schiaffino A, Alonso J, Herdman M.

Qual Life Res. 1998 May;7(4):311-22.

PMID:
9610215
15.

EQ-5D in a general population survey--a description of the most commonly reported EQ-5D health states using the SF-36.

Nordlund A, Ekberg K, Kristenson M.

Qual Life Res. 2005 May;14(4):1099-109.

PMID:
16041905
16.

Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore.

Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J.

Ann Acad Med Singapore. 2003 Sep;32(5):685-90.

PMID:
14626802
17.

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ.

Med Care. 2005 Nov;43(11):1078-86.

PMID:
16224300
18.

A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.

Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J.

J Rheumatol. 2003 Oct;30(10):2268-74.

PMID:
14528528
19.

The health status of the Dutch population as assessed by the EQ-6D.

Hoeymans N, van Lindert H, Westert GP.

Qual Life Res. 2005 Apr;14(3):655-63.

PMID:
16022059
20.

Comparing SF-6D and EQ-5D utilities across groups differing in health status.

Kontodimopoulos N, Pappa E, Papadopoulos AA, Tountas Y, Niakas D.

Qual Life Res. 2009 Feb;18(1):87-97. doi: 10.1007/s11136-008-9420-8.

PMID:
19051058

Supplemental Content

Support Center